Meldungen sortieren nach Relevanz Meldungsdatum
|
InteRNA Technologies Secures Additional Equity Financing to Progress Lead Program for Melanoma Treatment
, Forschung und Entwicklung, InteRNA Technologies B.V
InteRNA Technologies B.V., a biopharma company engaged in the development of microRNA (miRNA)-based therapeutics for oncology, announces today the closing of an...
|
Sistemic and Leading CDMO, Progenitor Cell Therapy (PCT) Initiate Study on Novel Stem Cell Characterisation Technology
, Forschung und Entwicklung, Sistemic
Sistemic Limited (Sistemic), the miRNA profiling company with facilities in Glasgow, Scotland and Boston, announced today the signature of an agreement to allow...
|
|
InteRNA Technologies Receives Notice of Allowance for miRNA Sequences of its Lead Pre-Clinical Product
, Forschung und Entwicklung, InteRNA Technologies B.V
InteRNA Technologies B.V., a drug discovery and development company engaged in the development of microRNA (miRNA)-based therapeutics for oncology, announces that...
|
Naheema Daniela Blankenburg und Dr. Mirna Zeman erhalten Postdoc-Stipendien der Universität Paderborn
, Ausbildung / Jobs, Universität Paderborn
Naheema Daniela Blankenburg und Dr. Mirna Zeman heißen die beiden Wissenschaftlerinnen, die in diesem Jahr ein Postdoc-Stipendium der Universität Paderborn erhalten....
|
Cenix BioScience expands operations to U.S.
, FirmenIntern, Cenix BioScience GmbH
Cenix BioScience, a leading discovery-stage CRO and technology developer specialized in advanced RNAi screening, microRNA modulation and high content phenotyping,...
|
|
Sistemic to Work with TiGenix On Landmark EUR 5.9 Million, FP7 European Project Aiming at Developing an Innovative Rheumatoid Arthritis Cell Therapy Treatment Product
, Software, Sistemic
Sistemic is delighted to announce that its proprietary technology (SistemQC(TM) ) has been chosen to form a key part of the research and production process for a...
|
|
CYTOO, Cenix BioScience and Academic Collaborators Bioquant, EPFL and FTMC Receive a 4 M€ EU FP7 Grant to Launch MEHTRICS Consortium
, Forschung und Entwicklung, Cenix BioScience GmbH
CYTOO, a company that specializes in micropattern-enhanced cell-based assays, has teamed up with Cenix BioScience, a pioneer in developing industrial high-content...
|
Krebsstammzellen - Kurze RNA spielt eine wichtige Rolle
, Forschung und Entwicklung, Universität Regensburg
Krebsstammzellen sind besonders heimtückisch. Im Unterschied zu normalen Krebszellen überstehen Stammzellen eine Chemo- oder Strahlentherapie häufig unbeschadet....
|
|
Cenix BioScience Grows, Establishing New R&D Subsidiary in Flanders, Belgium
, Forschung und Entwicklung, Cenix BioScience GmbH
Cenix BioScience GmbH, a leading contract research organization specializing in RNA interference- (RNAi) and microRNA- (miRNA) based drug discovery, today announced...
|
Bayerische Patentallianz erhält Partnership-Bonuszahlung von Regulus
, Forschung und Entwicklung, Bayerische Patentallianz GmbH
Die Bayerische Patentallianz GmbH, die zentrale Patent- und Vermarktungsagentur von 28 bayerischen Universitäten und Hochschulen für angewandte Wissenschaften, erhält...
|
Roche and Exiqon Agree on Joint Marketing Approach for their RT PCR Assay Systems
, Kooperationen / Fusionen, Roche Diagnostics GmbH
Roche (SIX: RO, ROG; OTCQX: RHHBY) and Exiqon (NASDAQ OMX: EXQ) join marketing forces for Roche Applied Science's RealTime ready assays and Exiqon's miRCURY LNA(TM)...
|
|
Roche und Exiqon vereinbaren gemeinsames Marketingkonzept für ihre RT PCR-Assaysysteme
, Kooperationen / Fusionen, Roche Diagnostics GmbH
Roche (SIX: RO, ROG; OTCQX: RHHBY) und Exiqon (NASDAQ OMX: EXQ) werden in Zukunft die RealTime ready Assays von Roche Applied Science und das miRCURY LNA(TM) Universal...
|
febit Announces Operational Restructuring
, FirmenIntern, CBC Comprehensive Biomarker Center GmbH
febit today announced a restructuring as a consequence of its strategic focus on bloodbased microRNA biomarker discovery, febit's major business development in 2009/2010,...
|
|
febit meldet Restrukturierung des operativen Geschäfts
, FirmenIntern, CBC Comprehensive Biomarker Center GmbH
Wie die febit aus Heidelberg heute bekannt gab, wird sich das Unternehmen künftig auf die Entdeckung und Validierung von microRNA (miRNA)-Biomarker Signaturen aus...
|
|
MiRNA Signatures Show Promising Potential as Biomarkers for Broad Range of Diseases
, Biotechnik, CBC Comprehensive Biomarker Center GmbH
The latest study results that illustrate the high potential of microRNAs (miRNAs) as biomarkers for a broad range of diseases will be presented during the 42nd European...
Ähnliche Keywords
Firmen
Kategorien
- Biotechnik (23)
- Forschung und Entwicklung (16)
- FirmenIntern (10)
- Finanzen / Bilanzen (8)
- Kooperationen / Fusionen (4)
Alle Kategorien
